{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:03:37Z","timestamp":1762430617046},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T00:00:00Z","timestamp":1333497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"DOI":"10.1007\/s00063-011-0065-y","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T11:26:50Z","timestamp":1333366010000},"source":"Crossref","is-referenced-by-count":2,"title":["Diagnose und Therapie der COPD-Exazerbation"],"prefix":"10.1007","author":[{"given":"T.T.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nilius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Gr\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rasche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,4]]},"reference":[{"key":"65_CR1","unstructured":"Rasche K (2011) COPD. In: Wilhelm W (Hrsg) Praxis der Intensivmedizin. Springer, Heidelberg, S\u00a0506\u2013513"},{"key":"65_CR2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/thorax.56.5.366","volume":"56","author":"Stockley","year":"2011","unstructured":"Stockley RA, Bayley D, Hill SL et al (2011) Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax 56(5):366\u2013372","journal-title":"Thorax"},{"key":"65_CR3","unstructured":"Diekmann M, Smidt U (1984) Berechnung eines Standard-paO2 in Analogie zum Standard-Bikarbonat. Atemw-Lungenkrkh 10(6):248\u2013250"},{"key":"65_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","volume":"131","author":"Stolz","year":"2007","unstructured":"Stolz D, Christ-Crain M, Bingisser R et al (2007) Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131(1):9\u201319","journal-title":"Chest"},{"key":"65_CR5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0029-1215037","volume":"63","author":"H\u00f6ffken","year":"2009","unstructured":"H\u00f6ffken G, Lorenz J, Kern W et al (2009) Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie \u2013 Update 2009. Pneumologie 63(10):e1\u2013e68","journal-title":"Pneumologie"},{"key":"65_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-2007-959200","volume":"61","author":"Vogelmeier","year":"2007","unstructured":"Vogelmeier C, Buhl R, Criee CP et al (2007) Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 61:323\u2013340","journal-title":"Pneumologie"},{"key":"65_CR7","unstructured":"Michael AA, Karen E Wills, Leigh B et al (2010) Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ 341"},{"key":"65_CR8","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2011) Global Strategy for the Diagnosis, Management and Prevention of COPD"},{"key":"65_CR9","first-page":"766","volume":"49","author":"Schumaker","year":"2004","unstructured":"Schumaker GL, Epstein SK (2004) Managing acute respiratory failure during exacerbation of chronic obstructive pulmonary disease. Respir Care 49(7):766\u2013782","journal-title":"Respir Care"},{"key":"65_CR10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-134-7-200104030-00016","volume":"134","author":"Bach","year":"2001","unstructured":"Bach PB, Brown C, Gelfand SE, McCrory DC (2001) Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 134(7):600\u2013620","journal-title":"Ann Intern Med"},{"key":"65_CR11","first-page":"CD003900","volume":"Rev","author":"McCrory","year":"2002","unstructured":"McCrory DC, Brown CD (2002) Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (4):CD003900","journal-title":"Cochrane Database Syst"},{"key":"65_CR12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","volume":"18","author":"Boe","year":"2001","unstructured":"Boe J, Dennis JH, O\u2019Driscoll BR et al (2001) European respiratory society guidelines on the use of nebulizers. Eur Respir J 18(1):228\u2013242","journal-title":"Eur Respir J"},{"key":"65_CR13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/archinte.1997.00440360162018","volume":"157","author":"Turner","year":"1997","unstructured":"Turner MO, Patel A, Ginsburg S, FitzGerald JM (1997) Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med 157(15):1736\u20131744","journal-title":"Arch Intern Med"},{"key":"65_CR14","first-page":"CD001288","volume":"Rev","author":"Wood-Baker","year":"2005","unstructured":"Wood-Baker RR, Gibson PG, Hannay M et al (2005) Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (1):CD001288","journal-title":"Cochrane Database Syst"},{"key":"65_CR15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1378\/chest.07-1207","volume":"133","author":"Quon","year":"2008","unstructured":"Quon BS, Gan WQ, Sin DD (2008) Contemporary management of acute exacerbations of COPD: A systematic review and metaanalysis. Chest 133(3):756\u2013766","journal-title":"Chest"},{"key":"65_CR16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","volume":"340","author":"Niewoehner","year":"1999","unstructured":"Niewoehner DE, Erbland ML, Deupree RH et al (1999) Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of veterans affairs cooperative study group. N Engl J Med 340(25):1941\u20131947","journal-title":"N Engl J Med"},{"key":"65_CR17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","volume":"354","author":"Davies","year":"1999","unstructured":"Davies L, Angus RM, Calverley PM (1999) Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 354:456\u2013460","journal-title":"Lancet"},{"key":"65_CR18","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1056\/NEJMoa023161","volume":"348","author":"Aaron","year":"2003","unstructured":"Aaron SD, Vandemheen KL, Hebert P et al (2003) Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 348(26):2618","journal-title":"N Engl J Med"},{"key":"65_CR19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1378\/chest.95.3.563","volume":"95","author":"Emerman","year":"1989","unstructured":"Emerman CL, Connors AF, Lukens TW et al (1989) A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD. Chest 95(3):563\u2013567","journal-title":"Chest"},{"key":"65_CR20","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/archinternmed.2011.530","volume":"171","author":"Alia","year":"2011","unstructured":"Alia I, Cal MA de la, Esteban A et al (2011) Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med 171(21):1939\u20131946","journal-title":"Arch Intern Med"},{"key":"65_CR21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1378\/chest.119.3.726","volume":"119","author":"Sayiner","year":"2001","unstructured":"Sayiner A, Aytemur ZA, Cirit M, Unsal I (2001) Systemic glucocorticoids in severe exacerbations of COPD. Chest 119(3):726\u2013730","journal-title":"Chest"},{"key":"65_CR22","first-page":"CD006897","volume":"Rev","author":"Walters","year":"2011","unstructured":"Walters JA, Wang W, Morley C et al (2011) Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (10):CD006897","journal-title":"Cochrane Database Syst"},{"key":"65_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1440-1843.2003.00468.x","volume":"8","author":"Li","year":"2003","unstructured":"Li H, He G, Chu H et al (2003) A step-wise application of methylprednisolone versus dexamethasone in the treatment of acute exacerbations of COPD. Respirology 8(2):199\u2013204","journal-title":"Respirology"},{"key":"65_CR24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1164\/ajrccm.165.5.2109093","volume":"165","author":"Maltais","year":"2002","unstructured":"Maltais F, Ostinelli J, Bourbeau J et al (2002) Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 165(5):698\u2013703","journal-title":"Am J Respir Crit Care Med"},{"key":"65_CR25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.327.7416.643","volume":"327","author":"Barr","year":"2003","unstructured":"Barr RG, Rowe BH, Camargo CA Jr (2003) Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials. BMJ 327(7416):643","journal-title":"BMJ"},{"key":"65_CR26","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(01)07097-0","volume":"358","author":"Nouira","year":"2001","unstructured":"Nouira S, Marghli S, Belghith M et al (2001) Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet 358:2020\u20132025","journal-title":"Lancet"},{"key":"65_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","volume":"327","author":"Abernethy","year":"2003","unstructured":"Abernethy AP, Currow DC, Frith P et al (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 327(7414):523\u2013528","journal-title":"BMJ"},{"key":"65_CR28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1055\/s-2007-1024198","volume":"123","author":"Schonhofer","year":"1998","unstructured":"Schonhofer B, Kohler D (1998) Stellenwert von oral appliziertem retardiertem Morphin zur Therapie des schwergradigen Lungenemphysems vom Pink-Puffer-Typ: Eine Pilotstudie. Dtsch Med Wochenschr 123(48):1433\u20131438","journal-title":"Dtsch Med Wochenschr"},{"key":"65_CR29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1378\/chest.128.2.518","volume":"128","author":"Ai-Ping","year":"2005","unstructured":"Ai-Ping C, Lee KH, Lim TK (2005) In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest 128(2):518\u2013524","journal-title":"Chest"},{"key":"65_CR30","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(00)02323-0","volume":"355","author":"Plant","year":"2000","unstructured":"Plant PK, Owen JL, Elliott MW (2000) Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 355:1931\u20131935","journal-title":"Lancet"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-011-0065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-011-0065-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-011-0065-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:13:30Z","timestamp":1558577610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-011-0065-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,4]]},"references-count":30,"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s00063-011-0065-y","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,4]]}}}